Significant high level of CERK was observed in ER Positive (*p = 0.049) (Fig. 2A), nodal positive (*p = 0.047) (Fig. 2B) and late-stage breast cancer patients (*p = 0.037) (Fig. 2C). This evidence concerns the gene CERK and breast cancer.